Barclays’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.84M Buy
346,659
+170,779
+97% +$907K ﹤0.01% 2285
2025
Q1
$1.56M Sell
175,880
-28,171
-14% -$250K ﹤0.01% 2197
2024
Q4
$2.8M Buy
204,051
+13,808
+7% +$189K ﹤0.01% 2001
2024
Q3
$5.21M Buy
190,243
+109,931
+137% +$3.01M ﹤0.01% 1501
2024
Q2
$1.96M Sell
80,312
-64,767
-45% -$1.58M ﹤0.01% 1721
2024
Q1
$3.09M Sell
145,079
-54,116
-27% -$1.15M ﹤0.01% 1644
2023
Q4
$3.81M Buy
199,195
+56,823
+40% +$1.09M ﹤0.01% 1697
2023
Q3
$2.28M Buy
142,372
+13,068
+10% +$210K ﹤0.01% 1589
2023
Q2
$3M Buy
129,304
+24,794
+24% +$575K ﹤0.01% 1495
2023
Q1
$2.43M Sell
104,510
-36,937
-26% -$858K ﹤0.01% 1519
2022
Q4
$2.05M Buy
141,447
+7,203
+5% +$105K ﹤0.01% 1635
2022
Q3
$2.56M Buy
134,244
+100,291
+295% +$1.91M ﹤0.01% 1492
2022
Q2
$617K Sell
33,953
-37,062
-52% -$673K ﹤0.01% 2424
2022
Q1
$1.79M Sell
71,015
-42,698
-38% -$1.08M ﹤0.01% 1860
2021
Q4
$3.14M Buy
113,713
+11,289
+11% +$312K ﹤0.01% 1528
2021
Q3
$3.31M Buy
102,424
+56,376
+122% +$1.82M ﹤0.01% 1505
2021
Q2
$1.41M Sell
46,048
-47,437
-51% -$1.45M ﹤0.01% 1923
2021
Q1
$2.85M Buy
93,485
+7,295
+8% +$222K ﹤0.01% 1607
2020
Q4
$1.7M Sell
86,190
-68,401
-44% -$1.35M ﹤0.01% 1671
2020
Q3
$2.02M Buy
154,591
+83,442
+117% +$1.09M ﹤0.01% 1494
2020
Q2
$807K Sell
71,149
-125,948
-64% -$1.43M ﹤0.01% 2053
2020
Q1
$2.82M Sell
197,097
-202,150
-51% -$2.89M ﹤0.01% 1152
2019
Q4
$10.9M Buy
399,247
+326,653
+450% +$8.9M 0.01% 814
2019
Q3
$2.08M Sell
72,594
-45,061
-38% -$1.29M ﹤0.01% 1725
2019
Q2
$3.27M Buy
117,655
+69,909
+146% +$1.94M ﹤0.01% 1400
2019
Q1
$1.59M Buy
47,746
+17,953
+60% +$596K ﹤0.01% 1748
2018
Q4
$866K Sell
29,793
-69,048
-70% -$2.01M ﹤0.01% 1910
2018
Q3
$4.55M Buy
98,841
+62,660
+173% +$2.88M ﹤0.01% 1124
2018
Q2
$1.35M Sell
36,181
-45,427
-56% -$1.7M ﹤0.01% 1652
2018
Q1
$2.41M Buy
81,608
+16,268
+25% +$481K ﹤0.01% 1264
2017
Q4
$2.24M Sell
65,340
-24,767
-27% -$851K ﹤0.01% 1206
2017
Q3
$3.26M Sell
90,107
-33,776
-27% -$1.22M ﹤0.01% 979
2017
Q2
$3.2M Buy
123,883
+22,304
+22% +$576K ﹤0.01% 977
2017
Q1
$1.95M Sell
101,579
-13,678
-12% -$263K ﹤0.01% 1223
2016
Q4
$1.92M Buy
115,257
+8,273
+8% +$138K ﹤0.01% 1171
2016
Q3
$2.2M Buy
106,984
+92,161
+622% +$1.9M ﹤0.01% 1039
2016
Q2
$454K Buy
14,823
+6,371
+75% +$195K ﹤0.01% 1802
2016
Q1
$313K Buy
8,452
+5,135
+155% +$190K ﹤0.01% 1909
2015
Q4
$143K Sell
3,317
-26,945
-89% -$1.16M ﹤0.01% 2171
2015
Q3
$1.12M Sell
30,262
-21,048
-41% -$780K ﹤0.01% 1352
2015
Q2
$1.69M Sell
51,310
-109,711
-68% -$3.62M ﹤0.01% 1228
2015
Q1
$5.64M Buy
161,021
+79,501
+98% +$2.78M 0.01% 852
2014
Q4
$2.77M Buy
81,520
+44,141
+118% +$1.5M ﹤0.01% 1184
2014
Q3
$1.42M Buy
37,379
+11,403
+44% +$433K ﹤0.01% 1514
2014
Q2
$986K Buy
25,976
+510
+2% +$19.4K ﹤0.01% 1708
2014
Q1
$866K Sell
25,466
-126,953
-83% -$4.32M ﹤0.01% 1736
2013
Q4
$3.05M Buy
152,419
+101,888
+202% +$2.04M ﹤0.01% 1198
2013
Q3
$1.16M Buy
50,531
+41,783
+478% +$961K ﹤0.01% 1614
2013
Q2
$235K Buy
+8,748
New +$235K ﹤0.01% 2600